
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes—from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches—is creating a new reality for industry leaders, innovators, and strategists. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.
Key Features
•Understand the Interconnectedness of U.S. Federal Policies.
•Analyze the Strategic Impacts of Key Legislation and Executive Actions.
•Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.
•Analyze the Interplay of U.S. Federal Actions and Industry Operations.
•Formulate Adaptive Strategies for Industry Resilience.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Half-Title
- Title
- Copyright
- Contents
- Preface
- 1 Introduction: Adapting to Change
- 2 Key Forces Impacting Pharma
- 3 Additional Emerging Policy Dynamics
- 4 Small Businesses in the New Pharma Paradigm
- 5 Impact of/on Compounding Pharmacies
- 6 The Most Favored Nation (MFN) Drug Pricing Executive Order
- 7 Medicare Part B vs. Part D Drug Coverage
- 8 International Impacts on Pharma
- 9 Strategic Recommendations for the Pharmaceutical Industry
- 10 Conclusion: Forging the Future: Resilience and Value in Pharma’s New Era
- Index